Sunday, August 30, 2009 8:11:18 AM
Bigplay, I think we do not own enough shares too impress Mr Cao. I own some more than _bbb_ and a lot less than you have... Maybe the others can make our numbers count 
Better than sending another mail maybe someone who speaks english could call in at the next conference call and ask some questions? The most important ones would be these (in my opinion):
1. What is the status of the drugs mentioned in last summers 10Q? 4Q 2009 is done and those drugs have not been SFDA approved.
2. What is happening with LFAA drug? Is it through Phase III clinical trials? Has GNPH negotiated a final purchase price?
3. What is the normal time frame to have a drug reviewed by SFDA? For the FDA in the USA, a review of a new drug application takes roughly 18 months.
4. How many shares have already been bought back as announced in the 2 million dollar share-buyback program?
5. Can you give an actual number on shares that are held by insiders, Pope, Ardsley?
6. How many shares of GHII and LTUS does GNPH still own? Are there plans on sellig these?
7. What has happened to the once promised dividend for the pre-merger US shareholders? Can this be cancelled without any consequences?
8. Are there any new drugs in development besides the three in the pipeline and the LFAA? Or is GNPH first going to concentrate on those total four and the drugs acquired with the acquisition of Hongrui?
9. Can we expect more acquisitions or a merger within a year from now?
10. Is transfering money out of the PRC to the US still an issue? Will it be resolved in the near future? How will you be paying interest or repaying debentures if you can't transfer the money?
11. Are you considering paying a dividend to all shareholders ?(not as in question 9).
I must admit I think it is a bad sign they haven't replied to our mails in a serious matter. But on the other hand our mails could have ended up in a spam-filter or whatever....
But then again time will tell.
Better than sending another mail maybe someone who speaks english could call in at the next conference call and ask some questions? The most important ones would be these (in my opinion):
1. What is the status of the drugs mentioned in last summers 10Q? 4Q 2009 is done and those drugs have not been SFDA approved.
2. What is happening with LFAA drug? Is it through Phase III clinical trials? Has GNPH negotiated a final purchase price?
3. What is the normal time frame to have a drug reviewed by SFDA? For the FDA in the USA, a review of a new drug application takes roughly 18 months.
4. How many shares have already been bought back as announced in the 2 million dollar share-buyback program?
5. Can you give an actual number on shares that are held by insiders, Pope, Ardsley?
6. How many shares of GHII and LTUS does GNPH still own? Are there plans on sellig these?
7. What has happened to the once promised dividend for the pre-merger US shareholders? Can this be cancelled without any consequences?
8. Are there any new drugs in development besides the three in the pipeline and the LFAA? Or is GNPH first going to concentrate on those total four and the drugs acquired with the acquisition of Hongrui?
9. Can we expect more acquisitions or a merger within a year from now?
10. Is transfering money out of the PRC to the US still an issue? Will it be resolved in the near future? How will you be paying interest or repaying debentures if you can't transfer the money?
11. Are you considering paying a dividend to all shareholders ?(not as in question 9).
I must admit I think it is a bad sign they haven't replied to our mails in a serious matter. But on the other hand our mails could have ended up in a spam-filter or whatever....
But then again time will tell.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
